Ten companies kicked off Monday’s trading standing firmer amid a broader market decline, as investors digested company-specific developments and repositioned portfolios ahead of global health conferences in the next few days.
Meanwhile, the Dow Jones led the session’s bloodbath, dropping 1.18 percent, followed by the S&P 500, declining 0.92 percent, and the S&P 500, down 0.84 percent.
In this article, we spotlight the 10 standout performers on Monday and break down the reasons behind their gains.
To come up with the list, we considered only the stocks with a $2 billion market capitalization and more than 5 million shares in trading volume.
Photo by Tima Miroshnichenko on Pexels
10. Medical Properties Trust Inc. (NYSE:MPW)
Medical Properties saw its share prices jump by 3.94 percent on Monday to close at $5.14 apiece as investors took heart from a 12 percent increase in its upcoming quarterly dividend.
In a statement, Medical Properties Trust Inc. (NYSE:MPW) said common shareholders as of December 11 record would receive $0.09 worth of dividends on January 8, 2026.
“This dividend increase reflects our growing confidence in the strength of our portfolio and cash flow potential in the year ahead,” said Medical Properties Trust Inc. (NYSE:MPW) President and CEO Edward Aldag Jr.
“Together with our recently announced $150 million common stock repurchase program, we are well positioned to deliver additional value to our shareholders moving forward,” he added.
The dividend increase followed the company’s improved earnings performance in the third quarter of the year, having narrowed its net loss attributable to shareholders by 90 percent to $77.7 million from $801 million in the same period last year. Revenues also jumped by 4.96 percent to $237 million from $225.8 million year-on-year.
9. Caesars Entertainment Inc. (NASDAQ:CZR)
Caesars Entertainment rallied for a second day on Monday, adding 4.20 percent to close at $20.61 apiece as investors took path from Missouri’s legalization and official launch of mobile sports betting in the state.
Scheduled for official launch on December 1, the newly approved sports wagering market opened the door for gaming companies such as Caesars Entertainment Inc. (NASDAQ:CZR) to tap the state’s more than 6 million residents.
Ahead of the launch, Caesars Entertainment Inc. (NASDAQ:CZR) kicked off an early promotion for new users aged 21 and older who are able to register and fund their Caesars Sportsbook mobile app accounts by December 1.
The mobile app features a comprehensive sports wagering offerings such as Same Game Parlays, player props, futures, and live in-play betting markets, among others.
Bettors will also be able to access livestreaming of marquee sporting events, including NFL games, directly within the app.
The Caesars Sportsbook platform features quick payouts, a variety of deposit options, among others.
“We expect the Caesars Sportsbook mobile app with Universal Digital Wallet and the retail experiences we’re bringing to Caesars Rewards destinations in the Show Me State to build on this passion. We’re thankful to the Missouri Gaming Commission for making this initial mobile launch possible and look forward to the full launch on December 1,” said Caesars Digital President Eric Hession.
8. Sandisk Corp. (NASDAQ:SNDK)
Sandisk saw its share prices jump by 4.61 percent on Monday to close at $265.88 apiece as investors cheered the launch of the world’s smallest USB-C flash drive as it ramps up its product offerings to tap the rapidly growing storage market.
Carrying as much as 1 terabyte of storage, Sandisk Corp. (NASDAQ:SNDK) said it expects the new flash drive to stay put once plugged into a laptop’s USB-C port.
The new product is designed for students, professionals, and other users who need more space through a compact external drive.
Sandisk Corp. (NASDAQ:SNDK) said the new drive was designed for the latest breed of slim laptops and tablets.
“Today’s professionals and students are constantly on the move, carrying slim laptops and tablets from home to office, meetings or class. They need storage that’s easy to access and always ready—so they can keep moving without missing a beat,” said Christina Garza, director of global brand management at Sandisk Corp. (NASDAQ:SNDK).
“With its compact, leave-in design, the new SANDISK Extreme Fit drive delivers fast, high-capacity storage—ready when they need it, without the hassle of plugging and unplugging or losing connection to cloud services,” she added.
7. Ocular Therapeutix Inc. (NASDAQ:OCUL)
Ocular Therapeutix rallied for a second day on Monday, adding 5.22 percent to finish at $11.89 apiece as investors repositioned portfolios ahead of two healthcare conferences in the next few days.
Last week, Ocular Therapeutix Inc. (NASDAQ:OCUL) said that its chairman, president, and CEO, Pravin Dugel, would participate in a fireside chat at the Jefferies Global Healthcare Conference in London on Tuesday, November 18, as well as the Piper Sandler 37th Annual Healthcare Conference in New York on December 3, 2025. Investors are expected to closely watch out for cues about the company’s pipeline developments and outlook.
Earlier this month, Ocular Therapeutix Inc. (NASDAQ:OCUL) widened its net loss by 90 percent to $69.4 million from $36.49 million in the same period last year.
Revenues also dropped by 5.8 percent to $14.5 million from $15.4 million year-on-year, due to a significantly more challenging reimbursement environment for its eye treatment, Dextenza, in 2025.
6. ZIM Integrated Shipping Services Ltd. (NYSE:ZIM)
ZIM Integrated extended its winning streak to a 7th straight day on Monday, adding 6.18 percent to close at $17.01 apiece as investors gobbled up shares ahead of the results of its earnings performance for the third quarter of the year.
In a statement, ZIM Integrated Shipping Services Ltd. (NYSE:ZIM) said it is scheduled to release its financial and operating highlights before market open on Thursday, November 20. It will host a conference call to elaborate on the results.
For the full-year period, ZIM Integrated Shipping Services Ltd. (NYSE:ZIM) is targeting to achieve a range of $1.8 billion to $2.2 billion in adjusted EBITDA, or a raise of the lower end of the range versus $1.6 billion previously.
Adjusted EBIT is also expected to hit $550 million and $950 million, also an upgrade of the lower end range from the $350 million prior.
Founded in Israel in 1945, ZIM Integrated Shipping Services Ltd. (NYSE:ZIM) is a global container liner shipping company with established operations in more than 100 countries serving approximately 33,000 customers in over 330 ports worldwide.
5. Quantum Computing Inc. (NASDAQ:QUBT)
Quantum Computing grew its share prices for a second day on Monday, adding 8.49 percent to close at $11.50 apiece as investors loaded portfolios ahead of the launch of its newest reservoir computing system capable of edge-AI use.
In a statement, Quantum Computing Inc. (NASDAQ:QUBT) said that it will launch its system called Neurawave at the SuperCompute25 international conference in St. Louis, Missouri on November 18 to 20.
Neurawave represents a significant milestone as it is able to deliver a photonic computing system designed to meet industry standards and seamlessly integrates with existing computing infrastructures. It also offers a practical, scalable, and energy-efficient solution for high-performance applications.
By leveraging the dynamic properties of photonic systems, Neurawave delivers fast, energy-efficient performance ideal for field operations, industrial settings, and embedded applications, and adding hardware-based intelligence and data processing capabilities to QCi’s quantum products.
“This launch marks a good step forward for QCi. We are building photonic computing systems that not only push the boundaries of technology but also align with industry standards and integration requirements by making photonics-based computing practical and impactful,” said Quantum Computing Inc. (NASDAQ:QUBT) CEO Yuping Huang.
Aside from Neurawave, Quantum Computing Inc. (NASDAQ:QUBT) would also provide on-cloud demonstrations for its Dirac-3 quantum computer, allowing conference attendees to explore real-time quantum processing already in use today.
4. Sociedad Química y Minera de Chile SA (NYSE:SQM)
Sociedad Quimica extended its winning streak to a 4th straight day on Monday, jumping 9.02 percent to close at $59.47 apiece amid forecast that demand for the overall lithium industry could jump by 30 to 40 percent next year.
The stock rallied alongside its counterparts, namely Albemarle Corp., Lithium Americas, Lithium Argentina, Standard Lithium, and Sigma Lithium, among others, after Ganfeng Lithium Chairman Li Liangbin said that the group is forecasting 30 to 40 percent growth in lithium demand for next year. Ganfeng Lithium is one of the largest lithium producers globally.
Additionally, Li said that demand growth could drive lithium carbonate prices to a range of 150,000 yuan to 200,000 yuan per ton, and that current supply might not be able to keep up with the strong demand in the short term despite around 200,000 tons surplus this year.
In other news, Sociedad Química y Minera de Chile SA (NYSE:SQM) is scheduled to release the results of its third quarter financial and operating highlights after market close on Tuesday, November 18, where investors will also closely watch out for the company’s updated guidance for the industry.
3. Terns Pharmaceuticals, Inc. (NASDAQ:TERN)
Terns Pharmaceuticals rallied to a new record high on Monday, as investors gobbled up shares following its participation in a global healthcare conference.
At intra-day trading, the stock soared to its highest price of $26.12 before trimming gains to end the day just up by 13.30 percent at $25.56 apiece.
Over the weekend, members of Terns Pharmaceuticals, Inc.’s (NASDAQ:TERN) senior management presented updates and outlook about the company’s pipeline progress at the recently concluded first day session of the Jefferies Global Healthcare Conference in London.
One of its key pipelines is the TERN-701, a novel investigational candidate for the treatment of chronic myeloid leukemia.
In its ongoing phase 1 trial, the company reported an overall major molecular response rate (MMR) of 75 percent by week 24. Of the the total, 64 percent achieved MMR and 100 percent maintained MMR.
Additionally, the treatment showed encouraging safety and tolerability profile across all tested doses.
In other recent developments, Terns Pharmaceuticals, Inc. (NASDAQ:TERN) announced the results of its third quarter earnings performance, where it widened its net loss by 12 percent to $24.6 million from $21.9 million in the same period last year.
Loss from operations also grew by 11.2 percent to $27.7 million from $24.9 million year-on-year.
2. Jazz Pharmaceuticals plc (NASDAQ:JAZZ)
Jazz Pharmaceuticals soared to a new 52-week high on Monday, as investors cheered positive results from the clinical trial of its cancer treatment candidate, Ziihera.
At intra-day trading, the stock jumped to its highest price of $172.91 before trimming gains to finish the day just up by 20.57 percent at $170.09 apiece.
In a statement, Jazz Pharmaceuticals plc (NASDAQ:JAZZ) said that it recorded positive results for its phase 3 clinical trial for Ziihera, in combination with chemotherapy, with or without the PD-1 inhibitor Tevimbra.
According to Jazz Pharmaceuticals plc (NASDAQ:JAZZ), the trial showed that Ziihera in combination with chemotherapy; as well as in combination with both tislelizumab and chemotherapy; demonstrated highly statistically significant and clinically meaningful improvements in progression-free survival (PFS) compared to the control arm, trastuzumab plus chemotherapy.
The treatment, when combined with both chemotherapy and trastuzumab, also demonstrated clinically meaningful overall survival improvements in enrolled patients.
Jazz Pharmaceuticals plc (NASDAQ:JAZZ) plans to submit the data for presentation at a major medical meeting in the first quarter of 2026.
1. PACS Group, Inc. (NYSE:PACS)
PACS Group snapped a four-day losing streak on Monday, surging 48.39 percent to close at $15.70 apiece as investors poured funds back into the company following announcements that it is now ready to submit its late and updated regulatory filings by Wednesday, November 19.
In a statement, PACS Group, Inc. (NYSE:PACS) said that it would announce the results of its third quarter earnings performance after market close, and officially file outstanding annual and quarterly results through September 2030.
It can be learned that PACS Group, Inc. (NYSE:PACS) was given by the New York Stock Exchange until November 19 to continue trading on the exchange amid its failure to submit financial statements for the three months ended March 31, 2024; as well as the three and six months ended June 30, 2024.
The submission is required to regain compliance with the NYSE listing requirements and continue trading on the exchange.
“The Company today filed a Form 12b-25, Notification of Late Filing, with the SEC related to its Quarterly Report on Form 10-Q for the period ended September 30, 2025, which, as noted above, it expects to file on Wednesday, November 19. This is within the five-day extension period, in accordance with Rule 12b-25,” PACS Group, Inc. (NYSE:PACS) said.
While we acknowledge the potential of PACS to grow, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an AI stock that is more promising than PACS and that has 100x upside potential, check out our report about the cheapest AI stock.
READ NEXT: 20 Best AI Stocks To Buy Now and 30 Best Stocks to Buy Now According to Billionaires.
Disclosure: None. Insider Monkey focuses on uncovering the best investment ideas of hedge funds and insiders. Please subscribe to our free daily e-newsletter to get the latest investment ideas from hedge fund investor letters by entering your email below.
